This product is a recombinant human antibody that recognizes DLL4 (Delta-like ligand 4). The anti-DLL-4 monoclonal antibody was able to bind efficiently to DLL-4 expressed on the surface of cells. EC₅₀ value was calculated for the anti-DLL4 antibody ranges from 0.1 to 0.3 nM. The antibody can block the binding of DLL-4 to Notch-1 and efficiently inhibit the interaction of human DLL-4 with both human and rat Notch-1. It efficiently inhibited DLL-4 stimulation of Notch-1 target gene regulation.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-204 | Anti-Human DLL4 Recombinant Antibody (TAB-204) | ELISA, FC, IP, FuncS, IF, Neut, WB | IgG2 - kappa |
There are currently no Customer reviews or questions for TAB-222MZ. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.